Built to provide research that’s more actionable and strategically valuable, The Business Research Company’s 2026 market reports include market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, broader supply chain intelligence, emerging startup tracking, and in-depth product insights.
Hepatitis C Testing Market Value Growth And Long-Term Outlook
The hepatitis c testing market has experienced robust expansion in recent years. Forecasts indicate an increase from $1.32 billion in 2025 to $1.4 billion by 2026, reflecting a compound annual growth rate (CAGR) of 6.4%. Historically, this growth has stemmed from factors such as broader blood screening programs, an increase in hepatitis C infection rates, heightened awareness regarding diagnostics, the availability of advanced testing kits, and an uptick in public health surveillance efforts.
The hepatitis c testing market is projected to experience robust expansion over the coming years, anticipated to reach $1.78 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 6.1%. This growth during the forecast period is primarily driven by escalating global elimination initiatives, a rising demand for point-of-care diagnostics, wider access to molecular testing, increasing investments in infectious disease diagnostics, and a heightened emphasis on early intervention. Significant trends throughout this period include the increasing adoption of rapid diagnostic tests, more widespread application of molecular testing technologies, a growing focus on early disease screening, the expansion of high-throughput laboratory testing, and enhanced monitoring of treatment outcomes.
Get A Free Sample Report With In-Depth Market Insights:
Hepatitis C Testing Market Development Factors: What’s Supporting Demand?
The increasing occurrence of hepatitis infections is anticipated to boost the expansion of the hepatitis C testing market moving ahead. Hepatitis C is a viral infection that causes liver inflammation and can lead to significant liver damage if not addressed. The rise in hepatitis cases primarily stems from insufficient vaccination rates, which leave many individuals vulnerable and facilitate the virus’s transmission. Early detection of the virus through hepatitis C testing enables timely treatment, preventing liver damage and severe complications. Furthermore, it helps identify infected individuals, aiding in preventing further spread and improving disease management. For instance, in April 2024, according to the World Health Organization (WHO), a Switzerland-based intergovernmental organization responsible for global public health, over 50 million people are living with chronic hepatitis C virus infection globally, with approximately 1.0 million new infections occurring each year. Therefore, the growing incidence of hepatitis cases is stimulating the development of the hepatitis C testing market.
Hepatitis C Testing Market Segment Landscape: Which Areas Lead Development?
The hepatitis c testing market covered in this report is segmented –
1) By Test Type: Antibody Tests, Nucleic Acid Tests, Genotyping Tests
2) By Technology: Enzyme-Linked Immunosorbent Assay (ELISA), Rapid Diagnostic Tests, Polymerase Chain Reaction, Next-Generation Sequencing
3) By Application: Blood Screening, Viral Load Monitoring, Disease Diagnosis
4) By End-User: Hospital-Based Laboratories, Stand-Alone Laboratories, Other End-Users
Subsegments:
1) By Antibody Tests: Enzyme Immunoassay (EIA), Recombinant Immunoblot Assay (RIBA), Rapid Diagnostic Tests (RDTs)
2) By Nucleic Acid Tests (NATs): Quantitative Ribonucleic Acid (RNA) Tests, Qualitative Ribonucleic Acid (RNA) Tests, Transcription-Mediated Amplification (TMA), Reverse Transcription Polymerase Chain Reaction (RT-PCR)
3) By Genotyping Tests: Line Probe Assay (LiPA), Sequencing-Based Assay, Real-Time Polymerase Chain Reaction (PCR)-Based Genotyping
Hepatitis C Testing Market Trends Powering Strategic Industry Growth
Leading companies within the hepatitis C testing market are concentrating on developing sophisticated solutions, including dual antigen-antibody diagnostic tests, to facilitate more efficient screening and monitoring of the infection. An antigen-antibody diagnostic test identifies viral proteins (antigens) and immune response proteins (antibodies), making it possible to detect both active and past infections. This combined strategy provides a thorough evaluation of the infection status. For instance, in July 2023, Roche Diagnostics India Pvt. Ltd., an India-based supplier of diagnostic tests and systems, introduced Elecsys HCV Duo, a fully automated immunoassay designed to simultaneously and independently detect both HCV antigens and antibodies from a single plasma or serum sample. This advancement supports early diagnosis, assists in patient management, and corresponds with India’s national initiative to eliminate hepatitis C through prompt and exhaustive screening.
Hepatitis C Testing Market Industry Leaders And Competitive Landscape
Major companies operating in the hepatitis c testing market are F. Hoffmann-La Roche Ltd., Bayer AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Siemens Healthineers AG, Quest Diagnostics Incorporated, Hologic Inc., QuidelOrtho Corporation, Sysmex Corporation, Bio-Rad Laboratories Inc., SD Biosensor INC., QIAGEN N.V., DiaSorin S.p.A., Cepheid, OraSure Technologies Inc., Meridian Bioscience Inc., Trivitron Healthcare Private Limited, General Biologicals Corporation, Biogate Laboratories Ltd., Cosara Diagnostics Private Limited, BioGenex Life Sciences Private Limited
View The Full Hepatitis C Testing Market Report:
Hepatitis C Testing Market Top Region By Revenue And Market Share
North America was the largest region in the hepatitis C testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the hepatitis c testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
